Results 211 to 220 of about 504,196 (405)

Role of the cyclin-dependent kinase inhibitors in the development of cancer [PDF]

, 1995
Toshiyasu Hirama, HP Koeffler
openalex   +1 more source

Cyclin-dependent kinase inhibitor therapy for hematologic malignancies

Expert Opinion on Investigational Drugs, 2013
P. Bose, G. Simmons, S. Grant
semanticscholar   +1 more source

Drug design for cyclin-dependent kinase 9 (CDK9) inhibitors <i>in silico</i>. [PDF]

Biochem Biophys Rep
Asamitsu K, Hirokawa T, Okamoto T.
europepmc   +1 more source

S-phase-promoting cyclin-dependent kinases prevent re-replication by inhibiting the transition of replication origins to a pre-replicative state [PDF]

, 1995
Christian Dahmann, John F.X. Diffley, Kim Nasmyth   +2 more
openalex   +1 more source

Cyclin-Dependent Kinase Inhibition in Prostate Cancer: Past, Present, and Future. [PDF]

Cancers (Basel)
Siskin M, Economides MP, Wise DR.
europepmc   +1 more source

Somatic cell reprogramming for Parkinson's disease treatment

Ibrain, Volume 11, Issue 1, Page 59-73, Spring 2025.
The fundamental purpose of cell reprogramming to treat Parkinson's disease is to generate dopaminergic neurons (DAN) and do transplantation. There are two ways to accomplish this. One method is to induce cells into induced DA neurons (iDAN) directly or to induce cells into induced pluripotent stem cells and ultimately into iDAN in vitro. Another option
Xiaozhuo Li, Kevin Fang, Fengping Wang
wiley   +1 more source

Continuing Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Advanced Breast Cancer: A Meta-Analysis. [PDF]

Cancers (Basel)
Pathak N, Kumar S, Gimenez DM, Di Iorio M, Savill J, Berner-Wygoda Y, Li M, Valiente CM, Cuthbert D, Gupta A, Arteaga DP, Batra A, Amir E, Mittal A.   +13 more
europepmc   +1 more source

Role of PPARγ in Regulating a Cascade Expression of Cyclin-dependent Kinase Inhibitors, p18(INK4c) and p21(Waf1/Cip1), during Adipogenesis [PDF]

, 1999
Ron F. Morrison, Stephen R. Farmer
openalex   +1 more source

Targeting the Menin–KMT2A interaction in leukemia: Lessons learned and future directions

International Journal of Cancer, EarlyView.
Abstract Chromosomal rearrangements involving the Mixed Lineage Leukemia gene (MLL1, KMT2A) are defining a genetically distinct subset in about 10% of human acute leukemias. Translocations involving the KMT2A‐locus at chromosome 11q23 are resulting in the formation of a chimeric oncogene, where the N‐terminal part of KMT2A is fused to a variety of ...
Florian Perner, Jayant Y. Gadrey, Scott A. Armstrong, Michael W. M. Kühn   +3 more
wiley   +1 more source

Cyclin-dependent kinase 13 is indispensable for normal mouse heart development. [PDF]

J Anat
Waheed-Ullah Q, Wilsdon A, Abbad A, Rochette S, Bu'Lock F, Saed AA, Hitz MP, Brook JD, Loughna S.   +8 more
europepmc   +1 more source